Prefrontal cortical hypometabolism during low-dose interferon alpha treatment
The DOI matches its Crossref record.
Abstract
Objective To evaluate prospectively interferon alpha (IFN-alpha) associated effects on cerebral glucose metabolism and its correlation to neuropsychiatric symptoms during low-dose IFN-alpha-treatment. Methods Eleven patients treated with low-dose IFN-alpha for chronic hepatitis C were prospectively evaluated by neuropsychiatric tests and cerebral [18F]deoxyglucose positron emission tomography (FDG-PET) before and in the 12th week of treatment. PET images were spatially normalized, corrected for variance in global activity and pixel-based t-statistics were calculated for each set of PET scans using SPM96 software. Pixel-cluster with P Results In week 12 of IFN-alpha treatment, significant hypometabolism with a decrease of local activity ranging from 8 to 12% was found in all patients bilaterally in the prefrontal cortex (BA 9), which correlated in a covariate analysis with changes in depression score as measured by Beck's Depression Inventory. Additionally, hypermetabolism with a maximum increase in local activity of 6-8% was seen in all patients in putamina as well as the left occipital region (BA 18). Before IFN-alpha treatment, only 1/11 patient showed depressive symptomatology. After 3 months of treatment, 6/11 patients were classified as having mild to moderate depressive symptoms (P Conclusions Low-dose IFN-alpha therapy is associated with significant prefrontal hypometabolism. This hypometabolism covaried with depression score, but was even found in clinically non-depre…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Positron emission tomography (PET) studies have revealed that the application of IFN-α leads to increases in basal ganglia glucose metabolism (109, 110).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [109]
Citations
Cites
Still being checked.
Cited by
Items 101–149 of 149
Immune System Contributions to the Pathophysiology of Depression
Miller, A. H., & Raison, C. L. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.1.foc36 · Cited by 33
Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders
Haroon, E., & Miller, A. H. (2017) · Modern trends in psychiatry · doi:10.1159/000470805 · Cited by 22
Pethő, B., Kovács, M. Á., Simon, D., Tóth, T., Hajnal, A. S., Csulak, T., Hebling, D., Albert, N., Varga, E., Herold, M., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1321354 · Cited by 24
Matthews, S. C., Paulus, M. P., & Dimsdale, J. E. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.4.281 · Cited by 20
Neuropsychiatric Involvement in Systemic Lupus Erythematosus
Weiner, S. M., & Otte, A. (2004) · Springer eBooks · doi:10.1007/978-3-642-18773-5_15 · Cited by 18
Early Life Stress, Neuroinflammation, and Psychiatric Illness of Adulthood
Shin, S. H., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_6 · Cited by 20
Pawełczyk, T., Pawełczyk, A. M., Strzelecki, D., & Rabe‐Jabłońska, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.03.001 · Cited by 17
An extended concept of altered self: Chronic fatigue and post-infection syndromes
Jones, J. F. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.11.007 · Cited by 19
Cancer fatigue: a review for psychiatrists
Levy, M. R. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.01.004 · Cited by 16
Regional neuronal activity in patients with relapsing remitting multiple sclerosis
Baumgärtner, A., Frings, L., Schiller, F., Stich, O., Mix, M. D., Egger, K. E., Schluh, G., Rauer, S., & Meyer, P. T. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.13012 · Cited by 13
Hassaan, S. H., Darweesh, A. E. D. M., Khalifa, H., Ramadan, H. K., Hassany, S. M., Ahmed, G. K., & Moustafa, E. F. A. (2019) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217419858277 · Cited by 13
Lowe, X. R., Marchetti, F., Lu, X., & Wyrobek, A. J. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2008.12.012 · Cited by 15
Inflammation, sickness behaviour and depression
Dantzer, R., Castanon, N., Lestage, J., Moreau, M. M., & Capuron, L. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544293.013 · Cited by 13
Cytokines as Neuromodulators: Insights From Experimental Studies With Humans and Nonhuman Primates
Martins, D., & Harrison, N. A. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.06.037 · Cited by 23
Psychiatric Clearance for Patients Started on Interferon-Alpha-Based Therapies
Lotrich, F. E. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12121572 · Cited by 13
Oriolo, G., Blanco‐Hinojo, L., Navinés, R., Mariñó, Z., Martín‐Hernández, D., Cavero, M., Giménez, M. D., Caso, J. R., Capuron, L., Forns, X., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.03.008 · Cited by 14
Accelerated aging in people living with HIV: The neuroimmune feedback model
Schrock, J. M. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100737 · Cited by 18
Abe, K., Wada, A., Oshima, S., Kono, S., Takahashi, A., Kanno, Y., Imaizumi, H., Hayashi, M., Okai, K., Niwa, S., et al. (2016) · Hepatology Research · doi:10.1111/hepr.12721 · Cited by 9
Neuroimmune Mediators: Are Cytokines Mediators of Depression?
de Beaurepaire, R., Swiergiel, A. H., & Dunn, A. J. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch22 · Cited by 8
Regional brain structural alterations in reward and salience networks in asthma
Carrol, D., Busse, W. W., Frye, C. J., Klaus, D. R., Bach, J. C., Floerke, H. L., Bendlin, B. B., Zetterberg, H., Blennow, K., Heslegrave, A., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.01.028 · Cited by 6
Cognitive dysfunction related to chemotherapy and biological response modifiers
Wefel, J. S., Collins, R. G., & Kayl, A. E. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545900.009 · Cited by 8
Hypothesized Mechanisms of Cognitive Impairment During High-Intensity Acute Exercise
Jung, M., Kang, M., & Loprinzi, P. D. (2023) · Integrated science · doi:10.1007/978-3-031-15959-6_14 · Cited by 6
Felger, J. C. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-21054-9_16 · Cited by 6
Bassiony, M. M., Yousef, A. M., Raya, Y., El-Shabrawi, A., Fouad, E. A., & El-Shafeey, M. (2015) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2015.1064964 · Cited by 7
The Inflammatory Hypothesis of Depression
Soskin, D. P., Cassiello-Robbins, C. F., Isacoff, O. K., & Fava, M. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.4.413 · Cited by 5
Pawełczyk, T., Pawełczyk, A. M., Białkowska, J., Jabłkowski, M., Strzelecki, D., Dworniak, D., & Rabe‐Jabłońska, J. (2008) · PubMed · Cited by 5
Khuntia, D., Mathew, B. S., Meyers, C. A., Johnson, S. C., & Mehta, M. P. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545900.013 · Cited by 5
Barlow, S., Fahey, B., Smith, K. J., Passecker, J., Della-Chiesa, A., Hok, V., Day, J. S., Callaghan, C. K., & O’Mara, S. M. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.012 · Cited by 3
Hu, P., Yu, M., Chen, M., Chen, C.-Y., Kuo, H., Hung, C., Tseng, K., Lai, H., Peng, C., Wang, J., et al. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.05.039 · Cited by 2
Montet, J., Montalban, E., Dexpert, S., Magne, E., Beau, C., Forestier, D., Ledaguenel, P., Gostner, J. M., Fuchs, D., Aouizerate, B., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106547 · Cited by 3
Elsayed, H., Elsayed, M., Arafa, M., & El‐Bendary, M. (2012) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000407891.12614.d0 · Cited by 2
Quemada, C., Morales‐Asencio, J. M., Hurtado, M. M., & Martí‐García, C. (2022) · BMC Nursing · doi:10.1186/s12912-022-00870-w · Cited by 4
Borkowska, A., Halota, W., & RYBAKOWSKI, J. K. (2008) · Cited by 4
Interferon-α, Molecular Signaling Pathways and Behavior
Wang, J. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8_5 · Cited by 2
Treatment of Depression in Medical Illness
Raison, C. L., Purselle, D. C., Capuron, L., & Miller, A. H. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch9 · Cited by 2
Extrahepatic Manifestations of Chronic Hepatitis C Virus: Review of the Literature
Stoenescu, A. F., Florescu, S., Popescu, C. P., Lazăr, Ş., VANCEA, G., Ceaușu, E., & Calistru, P. I. (2024) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2024.19.2.365 · Cited by 1
Thein, H., & Dore, G. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_191 · Cited by 1
Implications of the inflammatory processes in major depressive episode
Purnichi, T., Grigoras, R. M., Marinescu, I. P., Parlog, M. C., Ristea, S., Paraschiv, G., Banu, R., DUICA, L. C., Manea, M. C., & Matei, V. P. (2017) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2017.1.2
Meyer, P. T., Gobbelé, R., Ludolph, A., Schaefer, W. M., Waberski, T.-D., & Schiel, M. (2009) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181abb655 · Cited by 1
Hepatitis C: a patient's journey from a psychiatrist's perspective
Badrakalimuthu, V. R., Rumball, D., & Chawla, A. V. (2011) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.109.007153 · Cited by 1
Imaging of the Antidepressant Drug Response Using SPECT and PET
Clauss, R. P., Zöttl, M., & Sathekge, M. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_12
Psychotic disorders as a complication of interferon- a treatment of hepatitis C
Borkowska, A., & RYBAKOWSKI, J. K. (2007)
Co-Occurrence of HIV, Hepatitis C, and Substance Use Disorders: Effects on Brain Functioning
González, R., Quartana, P. J., & Martin, E. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-434-6_10 · Cited by 1
Khan, M. A., Wani, M. A., Agarwal, N. B., & Yasmeen (2022) · Current Drug Therapy · doi:10.2174/1574885517666220617124629 · Cited by 1
Psychiatric Disturbances of Attention
Cohen, R. A. (2013) · Springer eBooks · doi:10.1007/978-0-387-72639-7_17
Changes in Cognition in Infectious Hepatitis C: A New Narrative Review
Garg, A., & Khan, M. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-32046-0_98-1
Changes in Cognition in Infectious Hepatitis C: A New Narrative Review
Garg, A., & Khan, M. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-73363-5_98
Pethő, B., Herold, R., Simon, D., Kovács, M. Á., Tóth, T., Albert, N., Hebling, D., Hajnal, A. S., Csulak, T., Herold, M., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1648202 · Cited by 1
Metadata
- Authors
- Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K.
- Affiliations
- University of Freiburg (DE)
- Venue
- Psychopharmacology
- Published
- 2000-11-17
- Volume
- 152
- Issue
- 4
- Pages
- 383-389
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2021594711
- Cited by
- 149
- References
- 0
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 9 · 2016: 6 · 2015: 9 · 2014: 5 · 2013: 7 · 2012: 5
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- interferon-alpha, low-dose interferon, brain glucose metabolism, depression, chronic hepatitis C, FDG-PET
- MeSH terms
- Adult, Antiviral Agents, Female, Glucose, Hepatitis C, Humans, Male, Middle Aged, Neuropsychological Tests, Prospective Studies, Tomography, Emission-Computed, Interferon-alpha, Prefrontal Cortex, Fluorodeoxyglucose F18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.